• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (2)
    • Infant care instructions-revised.
    • Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma.
    • See All 2 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma.

Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma. Cell Rep Med. 2021 10 19; 2(10):100411.

View in: PubMed

subject areas
  • Antineoplastic Agents, Immunological
  • Carcinoma, Squamous Cell
  • Cyclin-Dependent Kinase Inhibitor p16
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Janus Kinase 2
  • Mouth Neoplasms
  • Mutation
  • Neoadjuvant Therapy
  • Neoplasm Recurrence, Local
  • Programmed Cell Death 1 Receptor
  • PTEN Phosphohydrolase
  • Receptors, Antigen, T-Cell, alpha-beta
  • Survival Analysis
  • Th17 Cells
  • T-Lymphocytes, Regulatory
  • Treatment Outcome
  • Vascular Endothelial Growth Factor Receptor-3

authors with profiles
  • Chrystal Mary Paulos
  • David Michael Neskey
  • Carsten Krieg
  • Martin Romeo
  • Cynthia Timmers